chrisvoncsefalvay/vaers-outcomes huggingface dataset:
started experiencing more sensibility to light than usual and it lasted for 4 to 5 hours; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Mar2021 09:15 (Lot number: Unknown) at the age of 52 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PHOTOPHOBIA (non-serious) with onset 25Mar2021 00:45, outcome "recovered", described as "started experiencing more sensibility to light than usual and it lasted for 4 to 5 hours". Therapeutic measures were not taken as a result of photophobia. Additional information: The facility where the most recent COVID-19 vaccine was administered in other (as reported). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had no other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
feels like having the flu; Chills; light headache; sore arm; nausea; feels like vomiting; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (feels like having the flu), CHILLS (Chills), HEADACHE (light headache), MYALGIA (sore arm) and NAUSEA (nausea) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (feels like having the flu), CHILLS (Chills), HEADACHE (light headache), MYALGIA (sore arm), NAUSEA (nausea) and VOMITING (feels like vomiting). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Symptomatic treatment, at a dose of 1 dosage form. At the time of the report, INFLUENZA LIKE ILLNESS (feels like having the flu), CHILLS (Chills), HEADACHE (light headache), MYALGIA (sore arm), NAUSEA (nausea) and VOMITING (feels like vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided.
This spontaneous report was received from a nurse concerning a patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history or concomitant medication. On 01-DEC-2017, the patient was vaccinated with M-M-R II lot # M040558 and expiration date of 06-OCT-2017, intramuscularly for prophylaxis. Other suspect therapies included sterile diluent(STERILE DILUENT). No adverse effects were reported.
C3-C5 vesicular rash. As Zoster associated with fever and fatigue.
A cluster of 4 adult patients who received TUBERSOL, lot number C2909AA, and developed reactions to the skin testing which the doctor believed was a reaction to the vaccine, but not a true positive reaction. Initial information received on 30 December 2008 from a health professional. This case is for a 44 year old female, with no known medical history, who received TUBERSOL (lot C2909AA) and FLUARIX (GSK, lot number AFLUA350BA) on either the 17 or 18 November 2008. At that time, the patient had no illnesses and had received no other vaccines in the four previous weeks. On 20 November 2008, the patient had an unspecified reaction to the skin testing which the doctor believed was a reaction to the vaccine, but not a true positive reaction. The patient recovered on an unspecified date. Follow up information received on 29 January 2009 from a health care professional. On 18 November 2008 at 15:26 the patient received the TUBERSOL and FLUARIX. The patient developed a 70 mm area of erythema (specific area not provided) on 20 November 2008 at 09:26. The patient recovered from the event. No further information was provided. Follow up information received on 18 February 2009 from a health care professional. The erythema was located on the patient's left forearm. It was reported that the patient recovered in about one week on 15 December 2008. No treatment was necessary. No further information was provided. Follow up information received on 19 March 2009 from a health care professional. The TUBERSOL was administered intradermally in the left forearm and the FLUARIX was administered intramuscularly in the left deltoid. The erythema was located at the TUBERSOL injection site. It was reported that the patient recovered in about one week in November 2008. According to the reporter, no specific date was provided, but it was approximately 27 November 2008. Cases 2008-03694, 2008-04095, and 2008-04097, with the same reporter and the same TUBERSOL lot number, were created for the other three patients.
pt started with tremor RUE>LUE>legs  'shortly after' the vaccination, was improving by the time she was seen by me a couple of weeks later - no new medications or other decline in health
Information has been received from a female consumer with no known allergies, high blood pressure and a history of cold sores who approximately one year ago in 2007 was vaccinated with a single dose of zoster vaccine live (Oka/Merck). Concomitant therapy included MICARDIS, atenolol, and clorazepate dipotassium. The patient stated she was very prone to getting cold sores. However, ever since she received the zoster vaccine live (Oka/Merck) vaccine she has had a single occurrence of cold sores. Medical attention was not sought and there were no lab studies performed. At the time of the report the patient's status was unknown. There was no product quality complaint involved. Follow-up information from the patient indicated that about a year ago while sick with the flu the usual cold sores did not form on her lips. The patient stated she could feel a big cold sore coming, but it never materialized into an "ugly blister." Additional information is not expected.
Skin is risen in the injection site area and large red circular mark where vaccine was administered. Area is tender to the touch.
Day of injection there was some slight site pain. Next day (today) my whole arm is sore. I can not even move it without severe pain. My lymph nodes in the left underarm is swollen and painful with the pain even in the left breast some.  Then, also this evening my left lower abdomen started having cramps and pain too.
04/2021 Blood test was taken after my second vaccination and the results showed I had hyperthyroidism and at my physical the physician found these levels alarming. I got an ultrasound, CT scan, and iodine scan of my thyroid to see if there are any issues resulting in the hyperthyroidism. I was referred over to an ENT specialist as well and looked at my nodules stating they were larger in size. I also saw an endocrinologist. They all noticed that the nodules are slightly enlarged. I was given a prescription for methimazole to manage my hyperthyroidism.
Information has been received from a consumer concerning her son who in April 2007 was vaccinated with the first 0.5 ml dose of MMR II. Concomitant therapy included Hep B (unspecified) (name and manufacturer unknown, but this vaccine had been withdrawn from the market due to side effects). In April 2007, the patient experienced seizures after getting vaccination. The patient had sought medical attention, he saw the physician. At the time of report the patient's status was recovered. Upon internal review, seizures was determined to be an other important medical event. No further information is available.
Pt was to be given 3rd HPV and H1N1.  Pt's sibling was also going to get same vaccines.  Pt. was agittaged because she didn't want to get shots.  LVN gave pt 2 injections on left deltoid.  He immediately told RN that he accidently gave pt.  2 HPV's instead of H1N1 and HPV.  Mother was notified MD notified. No adverse reaction.  Pt received 2 HPV's and (H1N1).
A non-serious spontaneous report of nose bleed has been received from a medical assistant concerning a child, male patient subsequent to FLUMIST.  This case is submitted in accordance with MedImmune's post-marketing commitment on accelerated reporting for the newly indicated population of 2 years to 59 months of age for FLUMIST.  No medical or drug history was reported for this patient.  The patient received FLUMIST at a pediatric clinic on 13-Nov-2008.  The patient experienced nose bleed while still in the office.  The outcome of the adverse event was not reported.
Got it done and still have it /suspected Vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got it done and still have it /suspected Vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 23-JUN-2023 This case was reported by a patient via interactive digital media. The patient stated to get yourself vaccinated. The patient reported she/he got Shingles vaccine done and still had shingles; it was not a joke. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
A month or so later I developed severe diarrhea every time I ate. I tried multiple OTC and dietary remedies. I lost 15#.  I was later diagnosed with microscopic colitis.
I have been experiencing red, irritated eyes, something which has never occurred before. My eyes look inflamed almost and I?ve been using basic Visine to make it better and it does make it go away for a little bit but the redness has been coming back. It could be an eye infection but again I take good care of my eyes and contacts and I?m wondering if this is a weird eye allergy side effect from the COVID shot.
Patient experience a syncope reaction. He fell forward from his chair and experienced some rug burn on his forehead.
On 01/14/2022 patient received a first dose of Moderna Covid-19 shot by the nurse that day. At the time patient was 12 years old and ineligible to receive a Moderna Vaccination due to age. On 02/11/2022, patient came in with mom and brother to receive his second dose. On 02/11/22, it was then realized that the patient had been given the wrong vaccine on 01/14/22 when looking at past consent form, covid vaccination card, and immunization record. Mom and patient were informed of the error. Both mom and patient state they did not notice any abnormal adverse events since receiving first dose. Patient also claims he has not had any heaviness in chest or the feeling of a rapid heart rate. No adverse event occurred and no treatment was needed.
Pt given PNEUMOVAX 23. The next day, Pt called to inform nurse he had a fever & (R) hand was swollen. Pt advised to come in immed. Pt Dx with cellulitis, placed on KEFLEX.
Woke up Monday, June 21 feeling fine, just a sore arm, and decided to do some mild exercise.  After bending at the waist for the fourth time, my heart started racing and I felt like I would faint.  The palpitations began at 10:40 AM and continued for 12 hours into the evening.  My normal approaches to bring them under control - bearing down, rest, homeopathic remedies and metoprolol - did nothing.  Heart rate was as high as 200+ and slowing dropped to 190 for several hours, 180 for several hours, 174 for awhile and after taking the homeopathic remedy thyroidinum it finally dropped to 94 and has gone back to normal.  Basically, I spent Monday day lying on my left side waiting for it to stop, trying to belly breathe slowly.  I had no appetite, felt faint each time I sat up.  Once the palpitations stopped, I have experienced shortness of breath whenever I go upstairs each day this week.  However, as I get further away from the vaccination day, the breathlessness is lessening.
Expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jan-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine). On 24-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products were reported. No treatment information was reported by the reporter.   Reporter did not allow further contact
pt recv vax 13OCT97 & exp itching, myalgia & nausea for 1-2 days;
THROAT SWELLING; RAPID HEART BEAT; DRY MOUTH; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included history of allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. Batch number was not reported and same has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced throat swelling, rapid heart beat, and dry mouth. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride, acetylsalicylic acid, and lorazepam. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from throat swelling, rapid heart beat, and dry mouth. This report was non-serious.
FAST IRREGULAR HEARTBEAT; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 29-JUL-2022 for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced fast irregular heartbeat. Laboratory data (dates unspecified) included: Heart rate Fast (Irregular). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of fast irregular heartbeat was not reported. This report was non-serious.
pt in ED with a positive COVID test; dx'd with respiratory failure; pt c/o N/V, SOB, cough; experienced 3 episodes of hematochezia; transferred to ICU; pt became unresponsive and vomited up blood; was intubated; bradycardia and no pulse; CPR started; pt never regained pulse or respirations
cough; sniffles; slight fever; Loss of taste; This spontaneous case was reported by a patient and describes the occurrence of COUGH (cough), RHINORRHOEA (sniffles), PYREXIA (slight fever) and AGEUSIA (Loss of taste) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COUGH (cough), RHINORRHOEA (sniffles), PYREXIA (slight fever) and AGEUSIA (Loss of taste). At the time of the report, COUGH (cough), RHINORRHOEA (sniffles), PYREXIA (slight fever) and AGEUSIA (Loss of taste) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-Apr-2021: New information included the additional event of loss of taste.
This spontaneous report was received from a physician via company representatives from a support services director concerning a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. Concomitant therapies were not provided. On 03-NOV-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (10Pk-0.5mL SD-PFS LLokw Tip) lot number K010466, expiration date of 23-MAR-2016 (route of administration was not reported). The vaccine had two temperature excursions: one for 24 hours and another for 32 hours. The lowest recorded temperature for the first excursion was 34 degrees Fahrenheit (1.111111111 Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several report received from the same reporter. Additional information has been requested.
Low blood platelets; This spontaneous case was reported by a consumer and describes the occurrence of PLATELET DISORDER (Low blood platelets) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included TOFACITINIB CITRATE (XELJANZ) for Rheumatoid arthritis.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PLATELET DISORDER (Low blood platelets). At the time of the report, PLATELET DISORDER (Low blood platelets) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: (Low) Low platelet count.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were reported.  No treatment medication were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-075604 (E2B Linked Report). This case was linked to MOD-2021-075604 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075604:Dose 1 case
CHIEF COMPLAINT/REASON FOR VISIT Recurrent pericardial effusion    HISTORY OF PRESENT ILLNESS Patient is a 49-year-old male who was directly admitted to the Cardiology service by for evaluation of recurrent pericardial effusions.  He has medical comorbidities including, but not limited to recurrent pericardial effusions status post pericardiocentesis, pericardial window, and VATS procedure, mild COVID-19 infection 7/2020, hyperlipidemia, diverticulitis in 2016, bilateral Bell's palsy 2010, anxiety, and insomnia.
so ill; muscle cramps; fever; headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (so ill), MUSCLE SPASMS (muscle cramps), PYREXIA (fever) and HEADACHE (headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No relevant medical history provided.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (so ill), MUSCLE SPASMS (muscle cramps), PYREXIA (fever) and HEADACHE (headache). At the time of the report, ILLNESS (so ill), MUSCLE SPASMS (muscle cramps), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication and treatment information were not provided.
become pregnant since receiving both doses; the common side effects, the day after vaccine and that it is not ongoing and self resolved within a day of receiving the vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (the common side effects, the day after vaccine and that it is not ongoing and self resolved within a day of receiving the vaccine) and MATERNAL EXPOSURE BEFORE PREGNANCY (become pregnant since receiving both doses) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 12-May-2022. On 16-Jan-2021, the patient experienced MATERNAL EXPOSURE BEFORE PREGNANCY (become pregnant since receiving both doses). On an unknown date, the patient experienced VACCINATION COMPLICATION (the common side effects, the day after vaccine and that it is not ongoing and self resolved within a day of receiving the vaccine). On 16-Jan-2021, MATERNAL EXPOSURE BEFORE PREGNANCY (become pregnant since receiving both doses) had resolved. At the time of the report, VACCINATION COMPLICATION (the common side effects, the day after vaccine and that it is not ongoing and self resolved within a day of receiving the vaccine) had resolved.            No relevant concomitant medication were provided.  No treatment information was provided. This case concerns a female patient, unknown age with no relevant medical history, who experienced the unexpected events of maternal exposure before pregnancy and vaccine complication. The event vaccine complication was said to occur one day after the vaccine. The rechallenge is unknown since details of vaccine complication was not disclosed. The benefit-risk relationship of is not affected by this report.   This case was linked to MOD-2021-326826 (Patient Link).   Reporter did not allow further contact; Sender's Comments: This case concerns a female patient, unknown age with no relevant medical history, who experienced the unexpected events of maternal exposure before pregnancy and vaccine complication. The event vaccine complication was said to occur one day after the vaccine. The rechallenge is unknown since details of vaccine complication was not disclosed. The benefit-risk relationship of is not affected by this report.